Catherine Avery Investment Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.89M Sell
53,596
-86
-0.2% -$10.1K 3.01% 9
2026
Q1
$6.46M Buy
53,682
+8,550
+19% +$987K 2.89% 12
2025
Q4
$4.75M Sell
45,132
-4,430
-9% -$416K 2.85% 9
2025
Q3
$4.16M Buy
49,562
+7,396
+18% +$609K 2.68% 21
2025
Q2
$3.34M Buy
42,166
+6,319
+18% +$502K 2.54% 20
2025
Q1
$3.22M Buy
35,847
+6,613
+23% +$617K 2.88% 17
2024
Q4
$2.91M Buy
+29,234
New +$3.01M 2.57% 24

Other funds holding MRK

Catherine Avery Investment Management's MRK Position: Q2 2026 in Review

Catherine Avery Investment Management reduced its Merck (MRK) stake by 0.16% in Q2 2026, selling an estimated $10.1K and leaving 53,596 shares worth $6.89M. The position accounts for 3.01% of the portfolio, ranked #9.

Catherine Avery Investment Management first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. 3,824 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Catherine Avery Investment Management held 53,596 shares of Merck worth $6.89M as of Q2 2026.
  • Catherine Avery Investment Management sold 86 Merck shares in Q2 2026, an estimated $10.1K.
  • Merck made up 3.01% of Catherine Avery Investment Management's portfolio in Q2 2026, its #9 holding.
  • Catherine Avery Investment Management first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • 3,824 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Catherine Avery Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.